fda approves first oral glp-1 obesity drug august 14 2025 Wegovy Pill Wins FDA Approval
Description
Targeted Nutritional Support.
Sitagliptin is the first of a class of drugs to be approved that mimics the actions of the dipeptidyl peptidase-4 (DPP-4) enzyme.
#doctor #health #weightloss #glp1
Download our eBook tolearn about the generation and function of active GLP-1 and why both are important aspects of type 2 diabetes research.
Use daily for best results and appetite support
